Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2000-07

AUTHORS

M Chang, SC Raimondi, Y Ravindranath, AJ Carroll, B Camitta, MV Gresik, CP Steuber, H Weinstein

ABSTRACT

The purpose of the paper was to define clinical or biological features associated with the risk for treatment failure for children with acute myeloid leukemia. Data from 560 children and adolescents with newly diagnosed acute myeloid leukemia who entered the Pediatric Oncology Group Study 8821 from June 1988 to March 1993 were analyzed by univariate and recursive partitioning methods. Children with Down syndrome or acute promyelocytic leukemia were excluded from the study. Factors examined included age, number of leukocytes, sex, FAB morphologic subtype, cytogenetic findings, and extramedullary disease at the time of diagnosis. The overall event-free survival (EFS) rate at 4 years was 32.7% (s.e. = 2.2%). Age > or =2 years, fewer than 50 x 10(9)/I leukocytes, and t(8;21) or inv(16), and normal chromosomes were associated with higher rates of EFS (P value = 0.003, 0.049, 0.0003, 0.031, respectively), whereas the M5 subtype of AML (P value = 0.0003) and chromosome abnormalities other than t(8;21) and inv(16) were associated with lower rates of EFS (P value = 0.0001). Recursive partitioning analysis defined three groups of patients with widely varied prognoses: female patients with t(8;21), inv(16), or a normal karyotype (n = 89) had the best prognosis (4-year EFS = 55.1%, s.e. = 5.7%); male patients with t(8;21), inv(16) or normal chromosomes (n = 106) had an intermediate prognosis (4-year EFS = 38.1%, s.e. = 5.3%); patients with chromosome abnormalities other than t(8;21) and inv(16) (n = 233) had the worst prognosis (4-year EFS = 27.0%, s.e. = 3.2%). One hundred and thirty-two patients (24%) could not be grouped because of missing cytogenetic data, mainly due to inadequate marrow samples. The results suggest that pediatric patients with acute myeloid leukemia can be categorized into three potential risk groups for prognosis and that differences in sex and chromosomal abnormalities are associated with differences in estimates of EFS. These results are tentative and must be confirmed by a large prospective clinical trial. More... »

PAGES

1201

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.leu.2401832

DOI

http://dx.doi.org/10.1038/sj.leu.2401832

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1019434822

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10914543


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analysis of Variance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Azacitidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosome Aberrations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosome Inversion", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosomes, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytarabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Etoposide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Life Tables", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multicenter Studies as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thioguanine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Translocation, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Florida", 
          "id": "https://www.grid.ac/institutes/grid.15276.37", 
          "name": [
            "Pediatric Oncology Group Statistical Office, University of Florida, Gainesville, Florida, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chang", 
        "givenName": "M", 
        "id": "sg:person.013142342372.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013142342372.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "St Jude Children's Research Hospital, Memphis, Tennessee, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raimondi", 
        "givenName": "SC", 
        "id": "sg:person.07717571264.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07717571264.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wayne State University", 
          "id": "https://www.grid.ac/institutes/grid.254444.7", 
          "name": [
            "Barbara Ann Karmanos Cancer Institute and Wayne State University, Detroit, Michigan, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ravindranath", 
        "givenName": "Y", 
        "id": "sg:person.01060351400.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060351400.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Alabama at Birmingham", 
          "id": "https://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Human Genetics, University of Alabama at Birmingham, Alabama, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carroll", 
        "givenName": "AJ", 
        "id": "sg:person.01175752651.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175752651.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Children's Hospital of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.414086.f", 
          "name": [
            "Midwest Children's Hospital, Milwaukee, Wisconsin, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Camitta", 
        "givenName": "B", 
        "id": "sg:person.016072551517.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016072551517.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baylor College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Baylor College of Medicine, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gresik", 
        "givenName": "MV", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baylor College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Baylor College of Medicine, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Steuber", 
        "givenName": "CP", 
        "id": "sg:person.01317670032.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317670032.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Massachusetts General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weinstein", 
        "givenName": "H", 
        "id": "sg:person.01233032233.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233032233.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-1-4612-4380-9_37", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007048162", 
          "https://doi.org/10.1007/978-1-4612-4380-9_37"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199501263320403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007194631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1996.d01-1761.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018882653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1996.d01-1761.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018882653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199605303342203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019019189"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2401508", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020816880", 
          "https://doi.org/10.1038/sj.leu.2401508"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2401508", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020816880", 
          "https://doi.org/10.1038/sj.leu.2401508"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.95.18.10860", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030002472"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0167-9473(86)90033-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030512955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199909303411407", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040310768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074481979", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074553961", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076061368", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077068234", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077278330", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1991.9.2.247", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077979515"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1991.9.4.572", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078193751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078440483", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079589299", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081834140", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082422019", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082488739", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1993.11.8.1448", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082762674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1996.14.1.18", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082858551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082878892", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082895213", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083076536", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083196326", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083321512", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-07", 
    "datePublishedReg": "2000-07-01", 
    "description": "The purpose of the paper was to define clinical or biological features associated with the risk for treatment failure for children with acute myeloid leukemia. Data from 560 children and adolescents with newly diagnosed acute myeloid leukemia who entered the Pediatric Oncology Group Study 8821 from June 1988 to March 1993 were analyzed by univariate and recursive partitioning methods. Children with Down syndrome or acute promyelocytic leukemia were excluded from the study. Factors examined included age, number of leukocytes, sex, FAB morphologic subtype, cytogenetic findings, and extramedullary disease at the time of diagnosis. The overall event-free survival (EFS) rate at 4 years was 32.7% (s.e. = 2.2%). Age > or =2 years, fewer than 50 x 10(9)/I leukocytes, and t(8;21) or inv(16), and normal chromosomes were associated with higher rates of EFS (P value = 0.003, 0.049, 0.0003, 0.031, respectively), whereas the M5 subtype of AML (P value = 0.0003) and chromosome abnormalities other than t(8;21) and inv(16) were associated with lower rates of EFS (P value = 0.0001). Recursive partitioning analysis defined three groups of patients with widely varied prognoses: female patients with t(8;21), inv(16), or a normal karyotype (n = 89) had the best prognosis (4-year EFS = 55.1%, s.e. = 5.7%); male patients with t(8;21), inv(16) or normal chromosomes (n = 106) had an intermediate prognosis (4-year EFS = 38.1%, s.e. = 5.3%); patients with chromosome abnormalities other than t(8;21) and inv(16) (n = 233) had the worst prognosis (4-year EFS = 27.0%, s.e. = 3.2%). One hundred and thirty-two patients (24%) could not be grouped because of missing cytogenetic data, mainly due to inadequate marrow samples. The results suggest that pediatric patients with acute myeloid leukemia can be categorized into three potential risk groups for prognosis and that differences in sex and chromosomal abnormalities are associated with differences in estimates of EFS. These results are tentative and must be confirmed by a large prospective clinical trial.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.leu.2401832", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2693343", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693338", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693333", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693331", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693295", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438833", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693349", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693162", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693341", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693527", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097065", 
        "issn": [
          "0887-6924", 
          "1476-5551"
        ], 
        "name": "Leukemia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821", 
    "pagination": "1201", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "5c99ba19e0ea528a47968aaf31f32030b083631f46dd5daa1a74837a1b076676"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10914543"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8704895"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.leu.2401832"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1019434822"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.leu.2401832", 
      "https://app.dimensions.ai/details/publication/pub.1019434822"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29182_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/2401832"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401832'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401832'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401832'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401832'


 

This table displays all metadata directly associated to this object as RDF triples.

362 TRIPLES      21 PREDICATES      91 URIs      55 LITERALS      43 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.leu.2401832 schema:about N0361d080dff84d57ac0723cfcfcff9d3
2 N03f023280d91464eaa89607b695ffb17
3 N0807677a035c475697c52e7273a6dc34
4 N0de92aa2799f43da8d11ae3f70c4a3a5
5 N102b7df1017e45ec9bbab41be9c6180f
6 N189bda7e8ab142878fc67a3a15eab2ac
7 N1d8ab62ca25442df9c30e325f9bf3460
8 N20285626b751416cb657cae53e8264a5
9 N2ad168fc56224e2fa883f3bf31b817fe
10 N30cdebb733d944afa620bc3a64d1c40c
11 N46e33d103b804e3f9716575af395159b
12 N480b1fa0b7194caab988c7a554f423c8
13 N5063e05e7d1c45a3b23451fd9a0ae803
14 N612bcc5bb9dc4b04ac05ce4d96f598ad
15 N6d5c1f4c0e884204b68a4c5a50322dbd
16 N784358e04eb54065bb4944857aff6bf3
17 N7b78312c9aad4219bdbf4702c41abeaa
18 N7db71bf769cd49cbb54f9b64690e86dc
19 N8b9289d0b9f9417dacb69201652688fc
20 N90faff2bfbef4888a2b0f49f0f843cff
21 N9a344362a99b44ad9217a184b5676cb3
22 N9e315635b7074a428fbdf29de72f3956
23 Nad6dd87ec5de4396b09a336bd8f4c32f
24 Nafc078c42bf141d7b1184d6f4d762559
25 Nca1434809b91417e90405626ffd6cd32
26 Nd359aca002eb4119b7d5ebf17e438d4b
27 Ne73e8419bada4df6bd721f0103301bac
28 Ne89cc6d4bd2e44a8bafa9f2d4d3ba295
29 Neb5ca80780cb49e99a9c97e2d2001a92
30 Nf07f4fc0620d4d72be907b26a4dfa0ff
31 Nf64a2ca8d248497f92fa529f9b312cdc
32 Nf870b96be3d54c2ca77c2dc71aa0325f
33 Nfe172005cb6c431c82104970826841e6
34 Nfeb27323bcb349f4827a9af1b09cc4b9
35 anzsrc-for:11
36 anzsrc-for:1112
37 schema:author Nf94148726a1d4dd2b59b0d767511c865
38 schema:citation sg:pub.10.1007/978-1-4612-4380-9_37
39 sg:pub.10.1038/sj.leu.2401508
40 https://app.dimensions.ai/details/publication/pub.1074481979
41 https://app.dimensions.ai/details/publication/pub.1074553961
42 https://app.dimensions.ai/details/publication/pub.1076061368
43 https://app.dimensions.ai/details/publication/pub.1077068234
44 https://app.dimensions.ai/details/publication/pub.1077278330
45 https://app.dimensions.ai/details/publication/pub.1078440483
46 https://app.dimensions.ai/details/publication/pub.1079589299
47 https://app.dimensions.ai/details/publication/pub.1081834140
48 https://app.dimensions.ai/details/publication/pub.1082422019
49 https://app.dimensions.ai/details/publication/pub.1082488739
50 https://app.dimensions.ai/details/publication/pub.1082878892
51 https://app.dimensions.ai/details/publication/pub.1082895213
52 https://app.dimensions.ai/details/publication/pub.1083076536
53 https://app.dimensions.ai/details/publication/pub.1083196326
54 https://app.dimensions.ai/details/publication/pub.1083321512
55 https://doi.org/10.1016/0167-9473(86)90033-2
56 https://doi.org/10.1046/j.1365-2141.1996.d01-1761.x
57 https://doi.org/10.1056/nejm199501263320403
58 https://doi.org/10.1056/nejm199605303342203
59 https://doi.org/10.1056/nejm199909303411407
60 https://doi.org/10.1073/pnas.95.18.10860
61 https://doi.org/10.1080/01621459.1958.10501452
62 https://doi.org/10.1200/jco.1991.9.2.247
63 https://doi.org/10.1200/jco.1991.9.4.572
64 https://doi.org/10.1200/jco.1993.11.8.1448
65 https://doi.org/10.1200/jco.1996.14.1.18
66 schema:datePublished 2000-07
67 schema:datePublishedReg 2000-07-01
68 schema:description The purpose of the paper was to define clinical or biological features associated with the risk for treatment failure for children with acute myeloid leukemia. Data from 560 children and adolescents with newly diagnosed acute myeloid leukemia who entered the Pediatric Oncology Group Study 8821 from June 1988 to March 1993 were analyzed by univariate and recursive partitioning methods. Children with Down syndrome or acute promyelocytic leukemia were excluded from the study. Factors examined included age, number of leukocytes, sex, FAB morphologic subtype, cytogenetic findings, and extramedullary disease at the time of diagnosis. The overall event-free survival (EFS) rate at 4 years was 32.7% (s.e. = 2.2%). Age > or =2 years, fewer than 50 x 10(9)/I leukocytes, and t(8;21) or inv(16), and normal chromosomes were associated with higher rates of EFS (P value = 0.003, 0.049, 0.0003, 0.031, respectively), whereas the M5 subtype of AML (P value = 0.0003) and chromosome abnormalities other than t(8;21) and inv(16) were associated with lower rates of EFS (P value = 0.0001). Recursive partitioning analysis defined three groups of patients with widely varied prognoses: female patients with t(8;21), inv(16), or a normal karyotype (n = 89) had the best prognosis (4-year EFS = 55.1%, s.e. = 5.7%); male patients with t(8;21), inv(16) or normal chromosomes (n = 106) had an intermediate prognosis (4-year EFS = 38.1%, s.e. = 5.3%); patients with chromosome abnormalities other than t(8;21) and inv(16) (n = 233) had the worst prognosis (4-year EFS = 27.0%, s.e. = 3.2%). One hundred and thirty-two patients (24%) could not be grouped because of missing cytogenetic data, mainly due to inadequate marrow samples. The results suggest that pediatric patients with acute myeloid leukemia can be categorized into three potential risk groups for prognosis and that differences in sex and chromosomal abnormalities are associated with differences in estimates of EFS. These results are tentative and must be confirmed by a large prospective clinical trial.
69 schema:genre research_article
70 schema:inLanguage en
71 schema:isAccessibleForFree true
72 schema:isPartOf N0b95fe3344ff46ddb98e7f6a740d56e9
73 Ncc772dcc66df4bff93c2cfc95e198181
74 sg:journal.1097065
75 schema:name Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821
76 schema:pagination 1201
77 schema:productId N0f681aa67d2141e8b98956d3f22aa55c
78 N2d112f444f034428b6dd0579f4b8117a
79 N89d3926db8fc4a0885b85a14a748300a
80 N99946947eb4e4075a33f549ae8694c3a
81 Ne4191b7fc87b4b7180485b0d46aaab41
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019434822
83 https://doi.org/10.1038/sj.leu.2401832
84 schema:sdDatePublished 2019-04-11T11:50
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher N68c68cc48f264f3f864be99114248f3c
87 schema:url https://www.nature.com/articles/2401832
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N0361d080dff84d57ac0723cfcfcff9d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Male
93 rdf:type schema:DefinedTerm
94 N03f023280d91464eaa89607b695ffb17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Etoposide
96 rdf:type schema:DefinedTerm
97 N069b93a38fe54f148ef452ff01c3c98a rdf:first sg:person.01317670032.09
98 rdf:rest Ne4bb6eaa0806416192610943cd05393f
99 N07a3cbc0d42643b7a1689a0d4b7f37d3 rdf:first sg:person.01060351400.12
100 rdf:rest Nb1d8b7d46f1044fc8101b3013a4fb10f
101 N0807677a035c475697c52e7273a6dc34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Multicenter Studies as Topic
103 rdf:type schema:DefinedTerm
104 N0b95fe3344ff46ddb98e7f6a740d56e9 schema:issueNumber 7
105 rdf:type schema:PublicationIssue
106 N0de92aa2799f43da8d11ae3f70c4a3a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Adolescent
108 rdf:type schema:DefinedTerm
109 N0f681aa67d2141e8b98956d3f22aa55c schema:name nlm_unique_id
110 schema:value 8704895
111 rdf:type schema:PropertyValue
112 N102b7df1017e45ec9bbab41be9c6180f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Azacitidine
114 rdf:type schema:DefinedTerm
115 N10c40975e0b24c6d8a61d3e831748a3e rdf:first sg:person.016072551517.65
116 rdf:rest N5c503efad8cb4f0e92fc1e3e81e6fc41
117 N189bda7e8ab142878fc67a3a15eab2ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Bone Marrow Transplantation
119 rdf:type schema:DefinedTerm
120 N1d8ab62ca25442df9c30e325f9bf3460 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Remission Induction
122 rdf:type schema:DefinedTerm
123 N20285626b751416cb657cae53e8264a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Thioguanine
125 rdf:type schema:DefinedTerm
126 N2ad168fc56224e2fa883f3bf31b817fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Risk Assessment
128 rdf:type schema:DefinedTerm
129 N2d112f444f034428b6dd0579f4b8117a schema:name doi
130 schema:value 10.1038/sj.leu.2401832
131 rdf:type schema:PropertyValue
132 N30cdebb733d944afa620bc3a64d1c40c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Doxorubicin
134 rdf:type schema:DefinedTerm
135 N46e33d103b804e3f9716575af395159b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Cohort Studies
137 rdf:type schema:DefinedTerm
138 N480b1fa0b7194caab988c7a554f423c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Risk Factors
140 rdf:type schema:DefinedTerm
141 N5063e05e7d1c45a3b23451fd9a0ae803 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Chromosomes, Human
143 rdf:type schema:DefinedTerm
144 N5c503efad8cb4f0e92fc1e3e81e6fc41 rdf:first N8465316ba5c34450a91d740d194898d1
145 rdf:rest N069b93a38fe54f148ef452ff01c3c98a
146 N612bcc5bb9dc4b04ac05ce4d96f598ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Survival Analysis
148 rdf:type schema:DefinedTerm
149 N68c68cc48f264f3f864be99114248f3c schema:name Springer Nature - SN SciGraph project
150 rdf:type schema:Organization
151 N6d5c1f4c0e884204b68a4c5a50322dbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name United States
153 rdf:type schema:DefinedTerm
154 N784358e04eb54065bb4944857aff6bf3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Treatment Outcome
156 rdf:type schema:DefinedTerm
157 N7b78312c9aad4219bdbf4702c41abeaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Translocation, Genetic
159 rdf:type schema:DefinedTerm
160 N7db71bf769cd49cbb54f9b64690e86dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Analysis of Variance
162 rdf:type schema:DefinedTerm
163 N8465316ba5c34450a91d740d194898d1 schema:affiliation https://www.grid.ac/institutes/grid.39382.33
164 schema:familyName Gresik
165 schema:givenName MV
166 rdf:type schema:Person
167 N89d3926db8fc4a0885b85a14a748300a schema:name pubmed_id
168 schema:value 10914543
169 rdf:type schema:PropertyValue
170 N8b9289d0b9f9417dacb69201652688fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Life Tables
172 rdf:type schema:DefinedTerm
173 N90faff2bfbef4888a2b0f49f0f843cff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Leukemia, Myeloid
175 rdf:type schema:DefinedTerm
176 N99946947eb4e4075a33f549ae8694c3a schema:name readcube_id
177 schema:value 5c99ba19e0ea528a47968aaf31f32030b083631f46dd5daa1a74837a1b076676
178 rdf:type schema:PropertyValue
179 N9a344362a99b44ad9217a184b5676cb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Combined Modality Therapy
181 rdf:type schema:DefinedTerm
182 N9e315635b7074a428fbdf29de72f3956 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Proportional Hazards Models
184 rdf:type schema:DefinedTerm
185 Nad6dd87ec5de4396b09a336bd8f4c32f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Disease-Free Survival
187 rdf:type schema:DefinedTerm
188 Nafc078c42bf141d7b1184d6f4d762559 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Chromosome Aberrations
190 rdf:type schema:DefinedTerm
191 Nb1d8b7d46f1044fc8101b3013a4fb10f rdf:first sg:person.01175752651.98
192 rdf:rest N10c40975e0b24c6d8a61d3e831748a3e
193 Nca1434809b91417e90405626ffd6cd32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Prognosis
195 rdf:type schema:DefinedTerm
196 Ncc772dcc66df4bff93c2cfc95e198181 schema:volumeNumber 14
197 rdf:type schema:PublicationVolume
198 Nd359aca002eb4119b7d5ebf17e438d4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Child
200 rdf:type schema:DefinedTerm
201 Ne366256d0d494fb88fffc42ef0c61730 rdf:first sg:person.07717571264.67
202 rdf:rest N07a3cbc0d42643b7a1689a0d4b7f37d3
203 Ne4191b7fc87b4b7180485b0d46aaab41 schema:name dimensions_id
204 schema:value pub.1019434822
205 rdf:type schema:PropertyValue
206 Ne4bb6eaa0806416192610943cd05393f rdf:first sg:person.01233032233.44
207 rdf:rest rdf:nil
208 Ne73e8419bada4df6bd721f0103301bac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Chromosome Inversion
210 rdf:type schema:DefinedTerm
211 Ne89cc6d4bd2e44a8bafa9f2d4d3ba295 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name Cytarabine
213 rdf:type schema:DefinedTerm
214 Neb5ca80780cb49e99a9c97e2d2001a92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Follow-Up Studies
216 rdf:type schema:DefinedTerm
217 Nf07f4fc0620d4d72be907b26a4dfa0ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Female
219 rdf:type schema:DefinedTerm
220 Nf64a2ca8d248497f92fa529f9b312cdc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name Humans
222 rdf:type schema:DefinedTerm
223 Nf870b96be3d54c2ca77c2dc71aa0325f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
224 schema:name Randomized Controlled Trials as Topic
225 rdf:type schema:DefinedTerm
226 Nf94148726a1d4dd2b59b0d767511c865 rdf:first sg:person.013142342372.25
227 rdf:rest Ne366256d0d494fb88fffc42ef0c61730
228 Nfe172005cb6c431c82104970826841e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
229 schema:name Treatment Failure
230 rdf:type schema:DefinedTerm
231 Nfeb27323bcb349f4827a9af1b09cc4b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
232 schema:name Antineoplastic Combined Chemotherapy Protocols
233 rdf:type schema:DefinedTerm
234 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
235 schema:name Medical and Health Sciences
236 rdf:type schema:DefinedTerm
237 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
238 schema:name Oncology and Carcinogenesis
239 rdf:type schema:DefinedTerm
240 sg:grant.2438833 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
241 rdf:type schema:MonetaryGrant
242 sg:grant.2693162 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
243 rdf:type schema:MonetaryGrant
244 sg:grant.2693295 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
245 rdf:type schema:MonetaryGrant
246 sg:grant.2693331 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
247 rdf:type schema:MonetaryGrant
248 sg:grant.2693333 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
249 rdf:type schema:MonetaryGrant
250 sg:grant.2693338 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
251 rdf:type schema:MonetaryGrant
252 sg:grant.2693341 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
253 rdf:type schema:MonetaryGrant
254 sg:grant.2693343 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
255 rdf:type schema:MonetaryGrant
256 sg:grant.2693349 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
257 rdf:type schema:MonetaryGrant
258 sg:grant.2693527 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
259 rdf:type schema:MonetaryGrant
260 sg:journal.1097065 schema:issn 0887-6924
261 1476-5551
262 schema:name Leukemia
263 rdf:type schema:Periodical
264 sg:person.01060351400.12 schema:affiliation https://www.grid.ac/institutes/grid.254444.7
265 schema:familyName Ravindranath
266 schema:givenName Y
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060351400.12
268 rdf:type schema:Person
269 sg:person.01175752651.98 schema:affiliation https://www.grid.ac/institutes/grid.265892.2
270 schema:familyName Carroll
271 schema:givenName AJ
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175752651.98
273 rdf:type schema:Person
274 sg:person.01233032233.44 schema:affiliation https://www.grid.ac/institutes/grid.32224.35
275 schema:familyName Weinstein
276 schema:givenName H
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233032233.44
278 rdf:type schema:Person
279 sg:person.013142342372.25 schema:affiliation https://www.grid.ac/institutes/grid.15276.37
280 schema:familyName Chang
281 schema:givenName M
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013142342372.25
283 rdf:type schema:Person
284 sg:person.01317670032.09 schema:affiliation https://www.grid.ac/institutes/grid.39382.33
285 schema:familyName Steuber
286 schema:givenName CP
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317670032.09
288 rdf:type schema:Person
289 sg:person.016072551517.65 schema:affiliation https://www.grid.ac/institutes/grid.414086.f
290 schema:familyName Camitta
291 schema:givenName B
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016072551517.65
293 rdf:type schema:Person
294 sg:person.07717571264.67 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
295 schema:familyName Raimondi
296 schema:givenName SC
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07717571264.67
298 rdf:type schema:Person
299 sg:pub.10.1007/978-1-4612-4380-9_37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007048162
300 https://doi.org/10.1007/978-1-4612-4380-9_37
301 rdf:type schema:CreativeWork
302 sg:pub.10.1038/sj.leu.2401508 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020816880
303 https://doi.org/10.1038/sj.leu.2401508
304 rdf:type schema:CreativeWork
305 https://app.dimensions.ai/details/publication/pub.1074481979 schema:CreativeWork
306 https://app.dimensions.ai/details/publication/pub.1074553961 schema:CreativeWork
307 https://app.dimensions.ai/details/publication/pub.1076061368 schema:CreativeWork
308 https://app.dimensions.ai/details/publication/pub.1077068234 schema:CreativeWork
309 https://app.dimensions.ai/details/publication/pub.1077278330 schema:CreativeWork
310 https://app.dimensions.ai/details/publication/pub.1078440483 schema:CreativeWork
311 https://app.dimensions.ai/details/publication/pub.1079589299 schema:CreativeWork
312 https://app.dimensions.ai/details/publication/pub.1081834140 schema:CreativeWork
313 https://app.dimensions.ai/details/publication/pub.1082422019 schema:CreativeWork
314 https://app.dimensions.ai/details/publication/pub.1082488739 schema:CreativeWork
315 https://app.dimensions.ai/details/publication/pub.1082878892 schema:CreativeWork
316 https://app.dimensions.ai/details/publication/pub.1082895213 schema:CreativeWork
317 https://app.dimensions.ai/details/publication/pub.1083076536 schema:CreativeWork
318 https://app.dimensions.ai/details/publication/pub.1083196326 schema:CreativeWork
319 https://app.dimensions.ai/details/publication/pub.1083321512 schema:CreativeWork
320 https://doi.org/10.1016/0167-9473(86)90033-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030512955
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1046/j.1365-2141.1996.d01-1761.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1018882653
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1056/nejm199501263320403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007194631
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1056/nejm199605303342203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019019189
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1056/nejm199909303411407 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040310768
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1073/pnas.95.18.10860 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030002472
331 rdf:type schema:CreativeWork
332 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
333 rdf:type schema:CreativeWork
334 https://doi.org/10.1200/jco.1991.9.2.247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077979515
335 rdf:type schema:CreativeWork
336 https://doi.org/10.1200/jco.1991.9.4.572 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078193751
337 rdf:type schema:CreativeWork
338 https://doi.org/10.1200/jco.1993.11.8.1448 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082762674
339 rdf:type schema:CreativeWork
340 https://doi.org/10.1200/jco.1996.14.1.18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082858551
341 rdf:type schema:CreativeWork
342 https://www.grid.ac/institutes/grid.15276.37 schema:alternateName University of Florida
343 schema:name Pediatric Oncology Group Statistical Office, University of Florida, Gainesville, Florida, USA
344 rdf:type schema:Organization
345 https://www.grid.ac/institutes/grid.240871.8 schema:alternateName St. Jude Children's Research Hospital
346 schema:name St Jude Children's Research Hospital, Memphis, Tennessee, USA
347 rdf:type schema:Organization
348 https://www.grid.ac/institutes/grid.254444.7 schema:alternateName Wayne State University
349 schema:name Barbara Ann Karmanos Cancer Institute and Wayne State University, Detroit, Michigan, USA
350 rdf:type schema:Organization
351 https://www.grid.ac/institutes/grid.265892.2 schema:alternateName University of Alabama at Birmingham
352 schema:name Department of Human Genetics, University of Alabama at Birmingham, Alabama, USA
353 rdf:type schema:Organization
354 https://www.grid.ac/institutes/grid.32224.35 schema:alternateName Massachusetts General Hospital
355 schema:name Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
356 rdf:type schema:Organization
357 https://www.grid.ac/institutes/grid.39382.33 schema:alternateName Baylor College of Medicine
358 schema:name Baylor College of Medicine, Houston, Texas, USA
359 rdf:type schema:Organization
360 https://www.grid.ac/institutes/grid.414086.f schema:alternateName Children's Hospital of Wisconsin
361 schema:name Midwest Children's Hospital, Milwaukee, Wisconsin, USA
362 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...